Skip to content

Clinical trials

Phase 3 Polyneuropathies trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polyneuropathies Phase: Phase 3 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20081
20091
20101
20111
20141
20151
20161
20191
20201
20211
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Withdrawn2
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eidos Therapeutics, a BridgeBio company4
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.3
Alnylam Pharmaceuticals1
Assistance Publique - Hôpitaux de Paris1
Baxalta now part of Shire1
Eastern Virginia Medical School1
Institut Mutualiste Montsouris1
Intellia Therapeutics1
Ionis Pharmaceuticals, Inc.1
Merck KGaA, Darmstadt, Germany1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polyneuropathies16
Amyloidosis7
Amyloid Neuropathies, Familial5
Peripheral Nervous System Diseases5
Alzheimer Disease4
Amyloidosis, Familial4
Diabetic Neuropathies3
Pain3
Cardiomyopathies2
Heart Diseases2

Trials

Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.